Search results: Company announcements for
ARGENICA THERAPEUTICS LIMITED (AGN)
Released between 01/01/2025 and 31/12/2025

Didn't find the announcement you were after? >Search again.

Announcements released as AGN
Date Price sens. Headline
29/12/2025
8:27 AM
  Non-Executive Chair Resignation
1 page 186.0KB
11/12/2025
9:11 AM
asterix AI Analysis Reveals Efficacy In Severe Stroke Patients
9 pages 437.3KB
04/12/2025
8:17 AM
asterix Positive TNK Study Results Fulfil Key FDA Requirement
3 pages 325.2KB
25/11/2025
9:16 AM
asterix ARG-007 Efficacious Dose Validated in New Preclinical Study
5 pages 351.3KB
12/11/2025
7:05 PM
  Final Director's Interest Notice
2 pages 306.7KB
12/11/2025
7:03 PM
  Results of Annual General Meeting
2 pages 275.9KB
12/11/2025
4:53 PM
  AGM Chair's Address & Presentation
28 pages 3.0MB
12/11/2025
4:49 PM
  Non-Executive Director Retirement
1 page 206.1KB
31/10/2025
9:16 AM
asterix Quarterly Activities/Appendix 4C Cash Flow Report
10 pages 491.5KB
21/10/2025
9:04 AM
  Investor Presentation - Cannacord Dug & Device Conference
18 pages 2.4MB
20/10/2025
1:16 PM
  Notification regarding unquoted securities - AGN
7 pages 21.1KB
15/10/2025
8:28 AM
asterix Phase 2 Trial Promising Improvements in Functional Outcomes
5 pages 468.9KB
13/10/2025
2:09 PM
  Notice of Annual General Meeting/Proxy Form
17 pages 639.0KB
24/09/2025
10:49 AM
  ASX Small Caps Conference Presentation
19 pages 2.4MB
17/09/2025
8:57 AM
  Date of AGM & Closing Date for Director Nominations
1 page 162.1KB
04/09/2025
8:17 AM
  Change in substantial holding
3 pages 222.1KB
03/09/2025
9:37 AM
  Investor Webinar
1 page 201.2KB
03/09/2025
9:35 AM
  Investor Presentation
16 pages 1.4MB
03/09/2025
9:34 AM
asterix Topline Phase 2 Trial Results of ARG-007 in AIS Patients
7 pages 391.8KB
01/09/2025
9:01 AM
asterix Trading Halt
2 pages 301.7KB
28/08/2025
5:06 PM
  Appendix 4G & Corporate Governance Statement
24 pages 687.1KB
28/08/2025
5:05 PM
asterix Appendix 4E & Annual Report to 30 June 2025
52 pages 2.5MB
14/08/2025
9:08 AM
asterix Argenica Receives IND Feedback From FDA
3 pages 266.3KB
08/08/2025
9:11 AM
  Bioshares Biotech Summit Presentation
20 pages 2.4MB
06/08/2025
8:15 AM
  Argenica Appoints Vice President of Regulatory Affairs
2 pages 205.9KB
23/07/2025
3:48 PM
  Ceasing to be a substantial holder from IFL
2 pages 59.7KB
23/07/2025
8:42 AM
asterix Quarterly Activities/Appendix 4C Cash Flow Report
10 pages 501.0KB
09/07/2025
5:04 PM
  Cleansing Notice
1 page 189.2KB
09/07/2025
5:03 PM
  Application for quotation of securities - AGN
6 pages 19.1KB
09/07/2025
5:02 PM
  Notification of cessation of securities - AGN
4 pages 14.8KB
09/07/2025
5:02 PM
  Application for quotation of securities - AGN
6 pages 18.5KB
20/06/2025
9:54 AM
asterix Argenica Awarded Federal Government Funding
2 pages 280.2KB
18/06/2025
8:49 AM
asterix Argenica to Progress Clinical Development in TBI
9 pages 484.8KB
10/06/2025
8:43 AM
asterix Update on Investigational New Drug Application
2 pages 217.6KB
03/06/2025
5:49 PM
  Change of Director's Interest Notice
3 pages 264.7KB
03/06/2025
5:46 PM
  Notification of cessation of securities - AGN
4 pages 14.8KB
03/06/2025
5:46 PM
  Notification regarding unquoted securities - AGN
6 pages 20.5KB
23/05/2025
8:58 AM
  Investor Webinar
1 page 202.7KB
22/05/2025
8:20 AM
asterix New US Patent for Surgical Stroke
2 pages 205.9KB
19/05/2025
10:19 AM
  Investor Presentation
25 pages 2.6MB
30/04/2025
8:09 AM
asterix Quarterly Activities/Appendix 4C Cash Flow Report
10 pages 486.6KB
11/04/2025
8:21 AM
asterix Last Patient Dosed in Phase 2 Stroke Trial
2 pages 278.6KB
01/04/2025
5:01 PM
  Notification of cessation of securities - AGN
4 pages 14.7KB
21/03/2025
5:06 PM
  Change of Share Registry Details
2 pages 183.2KB
12/03/2025
9:11 AM
  Investor Presentation
23 pages 2.5MB
03/03/2025
8:19 AM
  Final Director's Interest Notice
2 pages 308.3KB
03/03/2025
8:19 AM
  Non-Executive Director Resignation
1 page 196.4KB
11/02/2025
6:17 PM
asterix Half Yearly Report and Accounts
17 pages 977.1KB
04/02/2025
10:08 AM
asterix Updated - Main TBI Injury Study Annoucement
10 pages 522.9KB
04/02/2025
9:23 AM
asterix ARG-007 Shows Significant Neuroprotection in Main TBI Study
9 pages 511.9KB
30/01/2025
9:23 AM
asterix Quarterly Activities/Appendix 4C Cash Flow Report
12 pages 533.9KB
30/01/2025
9:17 AM
asterix Positive DSMB Safety Outcome & Phase 2 Trial Progress Update
3 pages 323.3KB

Useful Information

Didn't find the announcement you were after? >Search again.

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Other companies that have used the code 'AGN'

  • ANAGEN LIMITED

view available announcements for this company

  • AUSTRALIAN GEMSTONE HOUSE LIMITED

view available announcements for this company

  • AGEN LIMITED - previously known as
  • AUSTRALIAN GENETIC ENGINEERING LTD

view available announcements for this company